Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease

The risks and benefits of antiplatelet treatment may be different in patients with chronic kidney disease, in whom tendency to thrombosis and bleeding hazards might be increased. Chronic kidney disease is also associated with poor response to antiplatelet therapy, and this represents a potentially i...

Full description

Bibliographic Details
Main Authors: İbrahim Yıldız, Pınar Özmen Yıldız, Oben Döven
Format: Article
Language:English
Published: KARE Publishing 2014-07-01
Series:Türk Kardiyoloji Derneği Arşivi
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-08838